Walleye Trading’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-3,591
| Closed | -$628K | – | 4413 |
|
|
2025
Q4 | $610K | Buy |
+3,591
| New | +$551K | ﹤0.01% | 2697 |
|
|
2023
Q4 | – | Sell |
-9,548
| Closed | -$1.19M | – | 5279 |
|
|
2023
Q3 | $1.24M | Sell |
9,548
-2,753
| -22% | -$367K | ﹤0.01% | 2187 |
|
|
2023
Q2 | $1.52M | Buy |
+12,301
| New | +$1.66M | ﹤0.01% | 1857 |
|
|
2023
Q1 | – | Sell |
-1,168
| Closed | -$173K | – | 5102 |
|
|
2022
Q4 | $186K | Buy |
+1,168
| New | +$171K | ﹤0.01% | 3634 |
|
|
2022
Q3 | – | Sell |
-2,146
| Closed | -$326K | – | 5267 |
|
|
2022
Q2 | $335K | Buy |
+2,146
| New | +$330K | ﹤0.01% | 3310 |
|
|
2022
Q1 | – | Sell |
-262
| Closed | -$38K | – | 5597 |
|
|
2021
Q4 | $33K | Sell |
262
-13,035
| -98% | -$1.71M | ﹤0.01% | 4793 |
|
|
2021
Q3 | $1.73M | Sell |
13,297
-4,002
| -23% | -$605K | 0.01% | 1735 |
|
|
2021
Q2 | $3.07M | Buy |
17,299
+15,133
| +699% | +$2.62M | 0.01% | 1151 |
|
|
2021
Q1 | $356K | Buy |
2,166
+1,849
| +583% | +$304K | ﹤0.01% | 3045 |
|
|
2020
Q4 | $52K | Buy |
+317
| New | +$47.2K | ﹤0.01% | 4174 |
|
|
2020
Q2 | – | Sell |
-2,967
| Closed | -$328K | – | 4422 |
|
|
2020
Q1 | $296K | Buy |
+2,967
| New | +$384K | ﹤0.01% | 2308 |
|
|
2019
Q2 | – | Sell |
-5,047
| Closed | -$678K | – | 4257 |
|
|
2019
Q1 | $721K | Sell |
5,047
-9,701
| -66% | -$1.27M | 0.01% | 1942 |
|
|
2018
Q4 | $1.83M | Buy |
14,748
+1,113
| +8% | +$165K | 0.01% | 1140 |
|
|
2018
Q3 | $2.29M | Buy |
+13,635
| New | +$2.34M | 0.01% | 1194 |
|
|
2018
Q1 | – | Sell |
-932
| Closed | -$137K | – | 4615 |
|
|
2017
Q4 | $125 | Buy |
+932
| New | +$129K | ﹤0.01% | 3732 |
|
|
2017
Q3 | – | Sell |
-438
| Closed | -$66.2K | – | 4356 |
|
|
2017
Q2 | $68 | Sell |
438
-533
| -55% | -$81.5K | ﹤0.01% | 3749 |
|
|
2017
Q1 | $141 | Sell |
971
-30
| -3% | -$3.91K | ﹤0.01% | 3187 |
|
|
2016
Q4 | $109K | Buy |
1,001
+788
| +370% | +$87.8K | ﹤0.01% | 3197 |
|
|
2016
Q3 | $26K | Buy |
+213
| New | +$28.7K | ﹤0.01% | 4083 |
|
|
2016
Q2 | – | Sell |
-6,217
| Closed | -$916K | – | 5525 |
|
|
2016
Q1 | $812K | Buy |
6,217
+5,239
| +536% | +$652K | 0.01% | 1585 |
|
|
2015
Q4 | $137K | Buy |
978
+601
| +159% | +$83.3K | ﹤0.01% | 3038 |
|
|
2015
Q3 | $50K | Sell |
377
-1,025
| -73% | -$176K | ﹤0.01% | 3501 |
|
|
2015
Q2 | $247K | Buy |
+1,402
| New | +$252K | ﹤0.01% | 2293 |
|
Other funds holding JAZZ
VPM
VCM
EC
Walleye Trading's JAZZ Position: Q1 2026 in Review
Walleye Trading sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2026, closing a stake of 3,591 shares — an estimated $628K sold.
Walleye Trading first reported a position in JAZZ in Q2 2015 and held it in 23 quarters. The position peaked at $3.07M in Q2 2021. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- Walleye Trading reported no remaining Jazz Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
- Walleye Trading sold 3,591 Jazz Pharmaceuticals shares in Q1 2026, an estimated $628K.
- Walleye Trading first reported a position in Jazz Pharmaceuticals in Q2 2015 and held it in 23 quarters.
- Walleye Trading's Jazz Pharmaceuticals position peaked at $3.07M in Q2 2021.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.